MedPath

A clinical trial to study the effects of special type of radiation therapy-Intensity modulated radiotherapy and image guided brachytherapy in cervical cancer.

Phase 2
Conditions
Health Condition 1: C531- Malignant neoplasm of exocervix
Registration Number
CTRI/2020/08/027434
Lead Sponsor
Dr Madhup Rastogi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age: 18-65 years

Informed consent from the patient.

KPS score 70 or above.

Histopathologically proven Squamous Cell Carcinoma of carcinoma from stage IB2 to IVA (FIGO 2018)

Routine hematological, renal and hepatic functions should be with in normal range.

No contraindications of MRI.

No prior chemotherapy or radiotherapy and surgery

Exclusion Criteria

Any histopathology other than squamous cell carcinoma.

Patient having any synchronous or metachronous malignancy.

Patient having pre-existing renal or cardiovascular disease.

Patient hypersensitive to cisplatin.

Para-aortic lymph node positive.

Patient suffering from uncontrolled HIV, Hep B, Hep C.

Pregnant or lactating women.

Previous pelvic irradiation.

Patient with active inflammatory bowel disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath